Search icon

DOZO BIOTECHS INC

Company claim

Is this your business?

Get access!

Company Details

Name: DOZO BIOTECHS INC
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 05 Apr 2021 (4 years ago)
Entity Number: 5981358
ZIP code: 11801
County: Nassau
Place of Formation: New York
Address: 132 BROADWAY, HICKSVILLE, NY, United States, 11801
Principal Address: 132 Broadway, Hicksville, NY, United States, 11801

Shares Details

Shares issued 200

Share Par Value 0

Type NO PAR VALUE

DOS Process Agent

Name Role Address
DOZO BIOTECHS INC DOS Process Agent 132 BROADWAY, HICKSVILLE, NY, United States, 11801

Chief Executive Officer

Name Role Address
GURDIAL S ARORA Chief Executive Officer 132 BROADWAY, HICKSVILLE, NY, United States, 11801

Unique Entity ID

Unique Entity ID:
H48EBMGH5AW5
CAGE Code:
94CF3
UEI Expiration Date:
2022-11-02

Business Information

Activation Date:
2021-08-09
Initial Registration Date:
2021-07-27

Commercial and government entity program

CAGE number:
94CF3
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-03-02
CAGE Expiration:
2026-08-09
SAM Expiration:
2022-11-02

Contact Information

POC:
GURDIAL ARORA

History

Start date End date Type Value
2021-04-05 2024-01-29 Shares Share type: NO PAR VALUE, Number of shares: 200, Par value: 0
2021-04-05 2024-01-29 Address 132 BROADWAY, HICKSVILLE, NY, 11801, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
240129002042 2024-01-29 BIENNIAL STATEMENT 2024-01-29
210405010654 2021-04-05 CERTIFICATE OF INCORPORATION 2021-04-05

Trademarks Section

Serial Number:
90732289
Mark:
DOZBET
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Trademark
Application Filing Date:
2021-05-25
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
DOZBET

Goods And Services

For:
Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Herbal pills for the treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, a...
First Use:
2022-06-04
International Classes:
005 - Primary Class
Class Status:
ACTIVE

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 22 Mar 2025

Sources: New York Secretary of State